New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
13:25 EDTPLX, PLXSummer Street biotech analyst to hold an analyst/industry conference call
Chief Scientific Officer Classen discusses Protalix's PRX-112 for Gaucher disease on an Analyst/Industry conference call to be held on July 31 at 2 pm.
News For PLX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 13, 2014
10:27 EDTPLXProtalix offers to produce ZMapp Ebola treatment, i24News reports
Israeli company Protalix offered its resources to help produce ZMapp, the experimental Ebola treatment from privately-held MAPP Pharmaceuticals that has been in short supply, i24News reported previously on September 7. The circulation of a report from unitedwithisrael.org, which points back to the prior i24 report on Protalix, may be contributing to the early session strength in in the stock, which is up 18% this morning, according to contacts. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use